ALVO News and Press, Alvotech From 12/16/25

2025-12-16 15:19:05 ET Alvotech (ALVO) Discusses Launch of $125 Million Commercial Bond Offering and Business Update December 16, 2025 12:00 PM EST... Read the full article on Seeking Alpha For further details see: Alvotech (ALVO) Discusses Launch of $125 Million Commercial ...

2025-12-08 14:46:32 ET Since my article , "Regeneron: Strong R&D Pipeline Drives Growth Outlook," Regeneron Pharmaceuticals shares (NASDAQ: REGN ) have finally broken out of the accumulation phase, rising 27.4% to $718.4.... Read the full article on Seeking Alpha For...

2025-11-24 05:52:17 ET More on Alvotech Alvotech (ALVO) Q3 2025 Earnings Call Transcript Alvotech 2025 Q3 - Results - Earnings Call Presentation Alvotech: Initiating With Hold Rating On FDA CRL AVT05 And Reduced EBITDA Guidance Alvotech, Advanz Pharma secure ...

REYKJAVIK, Iceland, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Commission (EC) has approved AVT03 as a biosimilar to Prolia ...

2025-11-20 05:32:26 ET More on Alvotech Alvotech (ALVO) Q3 2025 Earnings Call Transcript Alvotech 2025 Q3 - Results - Earnings Call Presentation Alvotech: Initiating With Hold Rating On FDA CRL AVT05 And Reduced EBITDA Guidance Alvotech GAAP EPS of $0.47 beat...

REYKJAVIK, Iceland and LONDON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered gl...

The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Alvotech (“Alvotech” or the “Company”) (NASDAQ:ALVO) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal se...

2025-11-14 10:38:47 ET Thesis Teva Pharmaceutical Industries Limited ( TEVA ), founded in 1901 and based in Israel, has developed into one of the world’s leading generics drug companies. They rank closely with Sandoz ( SDZNY ), Viatris ( VTRS ) – formed...

2025-11-13 10:51:31 ET Alvotech (ALVO) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST Company Participants Benedikt Stefansson - VP of Investor Relations and Global Communications Robert Wessman - CEO, Founder & Executive Chairman Joseph McClellan - Chief ...

2025-11-12 17:04:43 ET More on Alvotech Alvotech: Initiating With Hold Rating On FDA CRL AVT05 And Reduced EBITDA Guidance Alvotech: Promising Vertically Integrated Biosimilar Platform Alvotech (ALVO) Presents At Morgan Stanley 23rd Annual Global Healthcare Conferenc...